Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Internet pharmacy 

Amazon applies for UK 'Amazon Pharmacy' trademark

The e-commerce firm has applied for the trademark linked to the provision of pharmaceuticals, medical and veterinary preparations, online pharmacy retail, the delivery of prescription medications, and other services. 

Amazon applies for UK 'Amazon Pharmacy' trademark

Source: Shutterstock.com/Amazon.com

Amazon has applied to the Intellectual Property Office for the trademarks that would be linked to the provision of pharmaceuticals, medical and veterinary preparations, online pharmacy retail, the delivery of prescription medications and other services

E-commerce and technology giant Amazon has applied for a UK trademark for the term Amazon Pharmacy.

On 9 January 2020, the company lodged two applications with the Intellectual Property Office (IPO) for the trademark that would be linked to the provision of pharmaceuticals, medical and veterinary preparations, online pharmacy retail, the delivery of prescription medications and other services.

The applications come six months after the company acquired the US online pharmacy PillPack, which operates in 49 US states.

In a statement, a spokesperson for PillPack told The Pharmaceutical Journal: “I can confirm that we’ve filed trademark applications for Amazon Pharmacy in the United States, Mexico, Canada, Brazil, UK, [the] EU, Turkey, United Arab Emirates, Egypt, Singapore, China, Japan, Taiwan, India, Australia, and Israel.

“We are always considering ways to delight customers in every market we serve. At present, our focus is on growing PillPack and offering a better pharmacy experience for customers in the United States.”

Sandra Gidley, president of the Royal Pharmaceutical Society (RPS), described the move as a “worrying development”.

“I think it’s a question of ‘watch this space’,” she said.

The government’s commitment in the Queen’s Speech on 19 December 2019 to introduce novel methods of dispensing medicines added more anxiety, she said.

“We will be monitoring the situation very closely and promoting the fact that there is no substitute with face-to-face interaction between a pharmacist and a patient. We will do all we can to make sure that Amazon is not allowed to dominate the pharmacy market.”

A spokesperson for the IPO explained that the trademark was in the first stage of being examined — the first step in the process of achieving approval.

They could not say how long the process might take and, if Amazon was successful, when it could operate according to the trademark terms in the UK.

The spokesperson explained: “That is down to Amazon — you do not have to register a mark to use it. The registration of a mark by an applicant provides the right to stop others from using that mark (if registered).”

Currently, Amazon offers its UK users access to a range of over-the-counter pharmacy products, such as nicotine replacement therapies, skin and dental hygiene products and vitamins.

In July 2019, the NHS announced a partnership with Amazon’s voice-assisted technology, ‘Alexa’, to provide healthcare information from the NHS website.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207617

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.